- External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
-
Lee JY, Chung YS, Na K, Kim HM, Park CK, Nam EJ, Kim S, Kim SW, Kim YT, Kim HS
- KMID: 2413200
- J Gynecol Oncol.
- 2017 Nov;28(6):e73.
- doi: 10.3802/jgo.2017.28.e73
OBJECTIVE: The chemotherapy response score (CRS) system based on histopathological examination has been recently proposed for tubo-ovarian high-grade serous carcinoma (HGSC) to assess response to neoadjuvant chemotherapy (NAC). This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Pitfall in Chemotherapy for Ovarian Cancer
-
Kamura T, Kim YT
- KMID: 1093954
- Yonsei Med J.
- 2002 Dec;43(6):779-782.
- doi: 10.3349/ymj.2002.43.6.779
Concerning the biological properties of recurrent ovarian cancer, other than drug resistance, we revealed that the expressions of mutant p53 and CD44v6 genes were significantly greater in recurrent ovarian cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell
-
Lee HG, Shin SJ, Chung HW, Kwon SH, Cha SD, Lee JE, Cho CH
- KMID: 2413456
- J Gynecol Oncol.
- 2017 Mar;28(2):e14.
- doi: 10.3802/jgo.2017.28.e14
OBJECTIVE: Cancer stem cells (CSCs) represent a subpopulation of undifferentiated tumorigenic cells thought to be responsible for tumor initiation, maintenance, drug resistance, and metastasis. The role of CSCs in drug... -
- CITED
-
- Close
- SHARE
-
- Close
